Skip to Main Content

The Food and Drug Administration announced Thursday that at least one person has died after a fecal microbiome transplant transmitted drug-resistant bacteria.

The FDA said one other person was also sick from the transplant; both people had weaker-than-normal immune systems and received stool from the same donor. The stool was not tested for a type of bacteria that produces an enzyme called beta-lactamase.


The agency did not disclose the location of the people and the name of the company or group that provided the stool.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!